His research work focused on computational modelling for the design and optimization of novel small molecules as potential next-generation inhibitors for elongation factors in Mycobacterium tuberculosis. His research interests include the development of machine learning models, artificial intelligence, molecular modelling, and Pharmacophore mapping.